Tuberculous peritonitis: an analysis of case series of 49 consecutive patients

Yıl 2024, Cilt: 10 Sayı: 1 - January 2024, 45 - 50, 04.01.2024

Elif Büyükkurt Ömer Yılmaz Bulent Albayrak Ezel Bilge Yerli

https://doi.org/10.18621/eurj.1278671

Öz

Objectives: The incidence of tuberculous peritonitis has been reported between 0.1% and 0.7% among all tuberculosis types. This study, it was aimed to evaluate the cases with tuberculous peritonitis, which has an important place in the differential diagnosis of patients with ascites, clinically, biochemically, microbiologically, and histopathologically.

Methods: : Forty-nine patients with a definite clinical, radiological, and histopathological diagnosis of tuberculous peritonitis, which formed the basis of our study, were analyzed retrospectively.

Results: The mean age of patients with tuberculous peritonitis was found to be 39.45 ± 19.02 years. Purified-protein derivative (PPD) was positive in 23 (72%) of 32 patients with tuberculous peritonitis whose PPD results were recorded, in 9 (28%) PPD results were evaluated as anergic or negative. QuantiFERON-TB Gold In-Tube (QFT-GIT) test was sent in 10 of the patients, the result was positive in 9 (90%) patients and negative in 1 (10%) patient. There were 32 patients in whom tuberculosis polymerase chain reaction (PCR) was studied from ascitic fluid, 7 (22%) of the patients were PCR positive and 25 (78%) negative. Mycobacterium tuberculosis culture positivity was found in 18 (69%) of 26 patients who were biopsied. In total, 29 (59%) of the patients had M. tuberculosis culture positivity.

Conclusions: Tuberculous peritonitis constitutes a public health problem in endemic regions of the world and tuberculous peritonitis should be considered in patients presenting with ascites. Despite all diagnostic difficulties, necessary tests, especially peritoneal biopsy, should be performed for early diagnosis, and it should not be forgotten that early initiation of treatment is very important in terms of morbidity and mortality of the disease.

Anahtar Kelimeler

Tuberculous peritonitis, diagnostic difficulties, ascites

Kaynakça

• 1. Demir K, Okten A, Kaymakoglu S, et al. Tuberculous peritonitis--Reports of 26 cases, detailing diagnostic and therapeutic problems. Eur J Gastroenterol Hepatol. 2001;13(5):581-585. doi: 10.1097/00042737-200105000-00019
• 2. Kushima H, Sakamoto R, Kinoshita Y, et al. Tuberculous peritonitis. BMJ Case Rep. 2021;14(10):e245311. doi: 10.1136/bcr-2021-245311.
• 3. Al-Knawy BA. Etiology of ascites and the diagnostic value of serum-ascites albumin gradient in non-alcohol liver disease. Ann Saudi Med. 1997;17(1):26-28. doi: 10.5144/0256-4947.1997.26.
• 4. Sanai FM, Bzeizi KI. Systematic review: tuberculous peritonitis–presenting features, diagnostic strategies, and treatment. Aliment Pharmacol Ther. 2005;22(8):685-700. doi: 10.1111/j.1365-2036.2005.02645.x.
• 5. Pullukçu H, Taşbakan MS, Sipahi OR, Taşbakan MI, Çalık Ş, Yamazhan T. Pooled analysis of extra-pulmonary tuberculosis in Turkey: a review of 2,168 patients. In: 18th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona, Spain; 2008. p. 1563.
• 6, Chow KM, Chow VC-Y, Szeto CC. Indication for peritoneal biopsy in tuberculous peritonitis. Am J Surg. 2003;185(6):567-573. doi: 10.1016/s0002-9610(03)00079-5.
• 7. Guirat A, Koubaa M, Mzali R, et al. Peritoneal tuberculosis. Clin Res Hepatol Gastroenterol. 2011;35(1):60-69. doi: 10.1016/j.gcb.2010.07.023
• 8. Chau TN, Leung VK, Wong S, et al. Diagnostic challenges of tuberculosis peritonitis in patients with and without end-stage renal failure. Clin Infect Dis. 2007;45(12):e141-146. doi: 10.1086/523727.
• 9. Fan L, Chen Z, Hao XH, et al. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol. 2012;65(3):456-466. doi: 10.1111/j.1574-695X.2012.00972.x.
• 10. Azghay M, Bouchaud O, Mechaï F, et al. Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis. Int J Infect Dis. 2016;44:25-30. doi: 10.1016/j.ijid.2016.01.004.
• 11. Koning M, van der Pol LM, Schippers EF. [Peritoneal tuberculosis]. Ned Tijdschr Geneeskd. 2017;161:D1372. [Article in Dutch]
• 12. Vardareli E, Kebapçi M, Saricam T, et al. Tuberculosis peritonitis of the wet acidic type: clinical features, and diagnostic value of image-guided peritoneal biopsy. Dig Liv Dis. 2004; 36(3):199-204. doi: 10.1016/j.dld.2003.10.016.
• 13. Khatri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347(18):1420-1425. doi: 10.1056/NEJMsa020098.
• 14. Woolas RP, Xu FJ, Jacobs IJ, et al. Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst. 1993;85(21):1748-1751. doi: 10.1093/jnci/85.21.1748.
• 15. Kosseifi S, Hoskere G, Roy TM, et al. Peritoneal tuberculosis: modern peril for an ancient disease. South Med J. 2009;102(1):57-59. doi: 10.1097/SMJ.0b013e39007c8.